Table 1.
Result for method | ||||||||
---|---|---|---|---|---|---|---|---|
Broth microdilution | Disk diffusion | |||||||
MIC breakpoints (μg/ml) | Zone diameter breakpoint (mm) | |||||||
Antimicrobial agent | Test range (μg/ml) | S | I | R | Disk conc. (μg) | S | I | R |
Ampicillin | 0.03–64.0 | ≤8 | 16 | ≥32 | 10 | ≥17 | 14–16 | ≤13 |
Ciprofloxacin | 0.03–64.0 | ≤1 | 2 | ≥4 | 5 | ≥21 | 16–20 | ≤15 |
Erythromycin | 0.03–64.0 | ≤8 | 16 | ≥32 | 15 | ≥23 | 14–22 | ≤13 |
Gentamicin | 0.03–64.0 | ≤2 | 4 | ≥8 | 10 | ≥15 | 13–14 | ≤12 |
Streptomycin | 0.03–64.0 | ≤2 | 4 | ≥8 | 10 | ≥15 | 12–14 | ≤11 |
Tetracycline | 0.03–64.0 | ≤4 | 8 | ≥16 | 30 | ≥15 | 12–14 | ≤11 |
Tylosin | 0.03–64.0 | ≤4 | 8 | ≥16 | NT | — | — | — |
Azithromycin | NT | — | — | — | 15 | ≥18 | 14–17 | ≤13 |
Chloramphenicol | NT | — | — | — | 30 | ≥18 | 13–17 | ≤12 |
Nalidixic acid | NT | — | — | — | 30 | ≥19 | 14–18 | ≤13 |
I, intermediate; MIC, minimum inhibitory concentrations; NT, not tested; R, resistance; S, susceptible.